Global Cardiovascular Interventional Devices Market Growth 2025-2031

The global Cardiovascular Interventional Devices market size is predicted to grow from US$ 14460 million in 2025 to US$ 23070 million in 2031; it is expected to grow at a CAGR of 8.1% from 2025 to 2031.

Cardiovascular interventional devices are medical instruments designed to assist in the diagnosis, treatment, and management of cardiovascular diseases through minimally invasive procedures. These devices are primarily used in interventions that address conditions such as coronary artery disease, peripheral artery disease, and heart valve disorders. Common types of cardiovascular interventional devices include stents, angioplasty balloons, guidewires, catheters, and embolization devices, which are used to open blocked arteries, place stents, or deliver targeted treatments without the need for invasive surgery. These devices have revolutionized cardiovascular care, enabling safer, more efficient treatments with shorter recovery times compared to traditional open-heart surgery.

The cardiovascular interventional devices market is primarily driven by the increasing global prevalence of cardiovascular diseases (CVDs), including coronary artery disease, heart failure, and peripheral artery disease. As the global population ages and lifestyle-related factors such as poor diet, lack of exercise, and smoking continue to contribute to the rise in cardiovascular conditions, the demand for minimally invasive treatments grows. Interventional procedures like angioplasty, stenting, and catheter-based diagnostics have become more common due to their lower risk, shorter recovery times, and reduced need for hospitalization. Furthermore, advancements in technology, including the development of bioabsorbable stents, improved imaging systems, and next-generation guidewires, continue to drive the market by offering safer, more efficient treatment options.

However, the cardiovascular interventional devices market faces challenges, such as the high cost of advanced devices and procedures, which can limit accessibility, particularly in developing countries or healthcare systems with budget constraints. Additionally, the complexity of these procedures requires specialized training and expertise, which may not be readily available in all healthcare settings, especially in low-resource regions. Despite the benefits of minimally invasive interventions, complications like stent restenosis, thrombosis, and device malfunctions continue to pose risks to patients, affecting overall treatment success. Furthermore, regulatory hurdles and lengthy approval processes for new devices can slow innovation and increase the time it takes for new technologies to reach the market.

The global top 5 players hold a market share over 70% in 2024. The key players are Boston Scientific Corporation, ABBOTT LABORATORIES, Medtronic, etc.

LP Information, Inc. (LPI) ' newest research report, the “Cardiovascular Interventional Devices Industry Forecast” looks at past sales and reviews total world Cardiovascular Interventional Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Cardiovascular Interventional Devices sales for 2025 through 2031. With Cardiovascular Interventional Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiovascular Interventional Devices industry.

This Insight Report provides a comprehensive analysis of the global Cardiovascular Interventional Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiovascular Interventional Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cardiovascular Interventional Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiovascular Interventional Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiovascular Interventional Devices.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Interventional Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Coronary Artery Stent
PTCA Balloon Catheter
Thread
Other

Segmentation by Application:
Angina Pectoris
Myocardial Infarction,
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Boston Scientific Corporation
ABBOTT
Medtronic
Terumo
NIPRO
B. Braun
Cook medical
Microport
Lepu medical
JW Medical
ASAHI INTECC
Kaneka Corporation
Sinomed
LifeTech Scientific Corporation
Gore
Acotec
Biotronik
Cordis

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cardiovascular Interventional Devices market?

What factors are driving Cardiovascular Interventional Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cardiovascular Interventional Devices market opportunities vary by end market size?

How does Cardiovascular Interventional Devices break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.